eCOA

IQVIA's Electronic Clinical Outcome Assessment (eCOA) solution is designed to support clinical trials by enabling real-time, direct-from-patient data collection. It is intended for pharmaceutical manufacturers, emerging biopharma, and clinical research organizations seeking to improve data accuracy, regulatory compliance, and patient engagement across study phases.

The solution replaces paper-based outcome assessment processes with electronic data capture, reducing transcription errors and improving the integrity of patient-reported, clinician-reported, observer-reported, and performance outcome data collected during trials.

Core Capabilities

• Real-time data collection directly from patients, reducing delays associated with paper-based methods
• Support for multiple outcome assessment types, including patient-reported outcomes (PRO), clinician-reported outcomes (ClinRO), observer-reported outcomes (ObsRO), and performance outcomes (PerfO)
• Improved data accuracy through electronic capture, minimizing manual transcription and data entry errors
• Compliance support aligned with regulatory requirements for clinical outcome assessments
• Tools designed to improve patient engagement and adherence to assessment schedules throughout the trial

Integration within the IQVIA Patient Suite

• eCOA is part of IQVIA's broader Patient Engagement Suite, which is designed to simplify trial operations and elevate the patient experience
• The solution connects with other IQVIA clinical technologies, including Interactive Response Technology (IRT) and Clinical Data Analytics Solutions
• Fits within IQVIA's Patient & Site Centric Solutions offering, which supports recruitment, engagement, and study execution for both patients and trial sites

Therapeutic and Study Coverage

• Applicable across a broad range of therapeutic areas, including oncology, central nervous system, cardiovascular, rare diseases, infectious diseases, and others supported by IQVIA's Centers of Excellence
• Supports early phase clinical trials through Phase IIb/III studies
• Designed to function within decentralized and hybrid trial models as well as traditional site-based studies

IQVIA eCOA is deployed as part of IQVIA's connected clinical technology ecosystem, which spans planning, site management, patient engagement, and data analytics. The solution is available globally, with IQVIA operating across the Americas, Europe, Asia Pacific, and the Middle East and Africa regions.